Latebreakers: Transdermal option given OK for Parkinson's disease

Article

A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.